Characteristics of Adrenocortical Carcinoma Associated With Lynch Syndrome

Author:

Domènech Marta12ORCID,Grau Elia13,Solanes Ares13,Izquierdo Angel145,del Valle Jesús1,Carrato Cristina6,Pineda Marta17,Dueñas Nuria17,Pujol Magda8,Lázaro Conxi17,Capellà Gabriel17,Brunet Joan137ORCID,Navarro Matilde137

Affiliation:

1. Hereditary Cancer Program, Catalan Institute of Oncology, Institut d’Investigació Biomédica de Bellvitge (IDIBELL), ONCOBELL Program, Hospitalet de Llobregat, Barcelona, Spain

2. Medical Oncology Department, Catalan Institute of Oncology, ICO-Badalona, Barcelona, Spain

3. Hereditary Cancer Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

4. Hereditary Cancer Program, Catalan Institute of Oncology, Hospital Josep Trueta, Girona, Spain

5. Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Girona, Spain

6. Pathology Department, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

7. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain

8. Pathology Department, Moises Broggi Hospital, Sant Joan Despí, Barcelona, Spain

Abstract

Abstract Context Lynch syndrome (LS) is the most common inherited colorectal and endometrial cancer syndrome, caused by germline mutations in DNA mismatch repair (MMR) genes. It is also characterized by an increased risk of other tumors with lower prevalence, such as adrenal cortical carcinoma (ACC), an endocrine tumor with an incidence of <2 cases/million individuals/year. Most ACC developed during childhood are associated with hereditary syndromes. In adults, this association is not as well established as in children. Previous studies showed a 3.2% prevalence of LS among patients with ACC. Evidence Acquisition The objective of this study is to determine the prevalence of ACC in a Spanish LS cohort and their molecular and histological characteristics. This retrospective study includes 634 patients from 220 LS families registered between 1999 and 2018. Evidence Synthesis During the follow-up period, 3 patients were diagnosed with ACC (0.47%); all were carriers of a MSH2 germline mutation. The 3 ACC patients presented loss of expression of MSH2 and MSH6 proteins. One tumor analysis showed loss of heterozygosity of the MSH2 wildtype allele. Our findings support previous data that considered ACC as a LS spectrum tumor. Conclusion MMR protein immunohistochemistry screening could be an efficient strategy to detect LS in patients with ACC.

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3